DTG
Discussion Brief
DTG & Emerson
Confidential

OT Scope — Global Site Overview

Emerson DeltaV footprint and engagement scope across AstraZeneca manufacturing sites.

Site Locations
Södertälje
Singapore
Charlottesville, VA
Gaithersburg, MD
Mount Vernon, VA
Macclesfield
Redwood City, CA
Coppell, TX
Frederick, MD
Newark, DE
Confirmed Sites
Location
Facility
Status
Comments
Södertälje
Sweden
Large Scale traditional API
DCS Solution delivered - but significant challenges now in commissioning and qualification - situation being assessed and recovery plans being formulated
Singapore
Singapore
ADC
Basic design closing out. Project approved to move into execution - DTG in discussions on Detailed Design/ execution support
Prospective Sites
Location
Facility
Status
Comments
Charlottesville, VA
USA
ADC, API, Continuous API, APF
Very early stages of concept design. Main engagement is on Autonomous so far - but DTG will be bidding to support AZ per Sweden/Singapore model
Gaithersburg, MD
USA
Clinical MoF (API, Continuous API)
Very early stages of concept design. Main engagement is on Autonomous so far - early discussions on OT scpoe
Mount Vernon, VA
USA
Secondary, Packing
Request for support on implementing site robotics programme
Macclesfield
UK
API, Continuous API
DTG have limited awareness so far - some light discussions on support for Continuous API scope. Keen to hear Emerson views
OT Baseline Sites
Location
Facility
Status
Comments
Redwood City, CA
USA
TBC
Early discussions on OT baseline/ assessment of technical debt for US sites
Coppell, TX
USA
Small Scale API
Early discussions on OT baseline/ assessment of technical debt for US sites
Frederick, MD
USA
Bio
Early discussions on OT baseline/ assessment of technical debt for US sites
Newark, DE
USA
Secondary, Packing, Distribution
Early discussions on OT baseline/ assessment of technical debt for US sites
✏️ Click any Facility or Comments cell to edit. Changes save automatically.

Discussion Points

1
Learning from Sweden
Context

Across the Sweden project, DTG and Emerson had multiple touchpoints. Emerson served as both the software and hardware provider and the system integrator. DTG operated as an extension of the AstraZeneca team, supporting them in the design of the system and representing their interests throughout.

What Happened
⚠️There were escalation points where AZ felt things were not going to plan — DTG supported AZ through these escalations as their trusted advisor.
🔁In parallel, DTG maintained back-channel dialogue with Emerson to manage relationships and work towards positive outcomes — often bridging the gap between the two parties.
DTG Recommendation

Rather than relying on reactive escalation when issues arise, DTG recommends establishing routine, proactive engagement between DTG and Emerson from the outset of any new site engagement. A structured working relationship — with regular touchpoints and agreed escalation paths — will deliver better outcomes for AstraZeneca and reduce friction for all parties.

2
Singapore — Working Together Through Detailed Design & Execution
Context

DTG has been supporting AstraZeneca Singapore through concept and basic design and is now competitively bidding for the detailed design and execution phase. It is DTG's understanding that Emerson will also be involved in this next phase. With both parties likely to be present, the question is how DTG and Emerson can best structure their working relationship to deliver the best outcome for AstraZeneca.

Discussion Point

Assuming both DTG and Emerson are successful in securing roles on this project — how do we structure our collaboration from the outset to support each other effectively and avoid the reactive dynamics seen in Sweden?

Areas to Align On
🗓️Joint engagement cadence — establishing a regular rhythm of DTG–Emerson touchpoints, independent of AZ-facing meetings, to surface and resolve issues early.
📣Escalation protocol — defining a shared, agreed approach for how issues are raised with AZ, so both parties present a coherent front rather than conflicting positions.
🌏Local context — DTG's existing relationships and design knowledge built through concept and basic design phases should be leveraged to accelerate Emerson's onboarding to the Singapore site specifics.
3
Broader Collaboration — Supporting Each Other as Common Scope Grows
📌To be discussed in depth tomorrow — teeing up the conversation here.

As DTG and Emerson find themselves working together across an increasing number of AstraZeneca sites — particularly in the US — the question of how to structure a broader collaborative relationship becomes strategically important. How can both organisations support each other in a way that scales, adds value for AZ, and positions DTG and Emerson as natural partners rather than parallel workstreams?